Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon

At present, for adults with chronic hepatitis B virus (HBV) infection, two new analogues, entecavir (ETV) and tenofovir, are recommended as the first-line therapy by the EASL (European Association for the Study of the Liver), AASLD (American Association for the Study of Liver Diseases), and APASL (A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology 2015-11, Vol.89 (Suppl 2), p.60-69
Hauptverfasser:	Kim, Soo Ki, Kim, Soo Ryang, Imoto, Susumu, Tohyama, Madoka, Otono, Yumi, Tamura, Tomoko, Kim, Ke Ih, Kobayashi, Mana, Ohtani, Aya, Sugimoto, Kayo, Mizuguchi, Aya, Hiramatsu, Yukiko, Kudo, Masatoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - therapeutic use Cancer therapies Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - prevention & control Carcinoma, Hepatocellular - virology Clinical Trials as Topic Complications and side effects Disease Management Drug therapy Drug Therapy, Combination Entecavir Guanine - analogs & derivatives Guanine - therapeutic use Hepacivirus - drug effects Hepacivirus - genetics Hepatitis Hepatitis B Hepatitis B virus Hepatitis C, Chronic - blood Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Hepatocellular carcinoma Humans Interferon Interferon-alpha - therapeutic use Japan - epidemiology Liver cancer Liver Neoplasms - epidemiology Liver Neoplasms - prevention & control Liver Neoplasms - virology Oncology Patient outcomes Practice Guidelines as Topic Prevention Prognosis Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!